
Dr. Reddy’s announces the launch of doxycycline capsules
HYDERABAD, India – Dr. Reddy’s Laboratories have announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Dr.